aspect
of
fund)
→
CapableOf
→
develop a quality assurance procedure
Typicality: | 0.250 |
Saliency: | 0.000 |
for retail sterile compounding pharmacies | 2 | transitive-object |
board → develop → a quality assurance procedure | 3 |
negative | neutral | positive |
0.020 | 0.826 | 0.154 |
Raw frequency | 3 |
Normalized frequency | 0.000 |
Modifier score | 0.500 |
Perplexity | 96.042 |